A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia.

Source:http://linkedlifedata.com/resource/pubmed/id/11729030

Download in:

View as

General Info

PMID
11729030